Document is current

Any future updates will be listed below

GX-I7, a long-acting IL-7, safely and effectively increased peripheral CD8+/CD4+ T cells and TILs in patients with locally advanced or metastatic solid tumours

Crossref DOI link: https://doi.org/10.1038/s41416-025-03069-3

Published Online: 2025-06-09

Published Print: 2025-09-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark